Dr. Daphne Haim-Langford, founder and CEO of Tarsier Pharma, a company developing disruptive medical solutions for the treatment of autoimmune and inflammatory blinding ocular diseases, is one of the three winner of the 2021 EU Prize for Women Innovators.
Follow Israel Hayom on Facebook and Twitter
Each of the winners will receive a 100,000 euro cash prize.
Haim-Langford has over 20 years of experience in the biomedical industry as a serial investor, entrepreneur and executive. She has led investments in the medical technology and biotechnology space, and served on the boards of pharmaceutical, medical device and biotechnology companies. She also co-founded the Israeli Biomimicry non-profit Organization, which promotes inspiration by nature as a source for innovation.
"Empowering women innovators is a global important mission that I strive to accomplish throughout my whole career. I believe that it is our responsibility as women leaders, to make sure many more women will follow us, and we should create opportunities and support the next generation," Haim-Langford said.
Chairman of the Israel Innovation Authority Dr. Ami Appelbaum congratulated Haim-Langford, saying, "By winning this illustrious award Daphne empowers other women researchers and entrepreneurs to break the glass ceiling and distinguish themselves in the various technology sectors and most particularly in medicine."
